- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4/A Registration of securities issued in business combination transactions
- 10.19 Securities Purchase Agreement, Dated As of February 2, 2022, by and Among Edoc Acquisition Corp. and 3I, LP
- 10.22 Registration Rights Agreement, Dated As of February 2, 2022, by and Among Edoc Acquisition Corp. and 3I, LP
- 10.28 Common Stock Purchase Agreement, Dated As of March 16, 2022, by and Among Edoc Acquisition Corp. and Tumim Stone Capital, LLC
- 10.29 Registration Rights Agreement, Dated As of March 16, 2022, by and Among Edoc Acquisition Corp. and Tumim Stone Capital, LLC
- 10.30 First Amendment to Securities Purchase Agreement, Dated As of March 16, 2022, by and Among Edoc Acquisition Corp. and 3I, LP
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Edoc
- 23.2 Consent of Mayer Hoffman Mccann P.C., Independent Registered Public Accounting Firm of Calidi
- Download Excel data file
- View Excel data file
- 12 Jan 23 RW Registration withdrawal request
-
25 May 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 16 Mar 22 S-4 Registration of securities issued in business combination transactions
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Amendment No. 1 to this Registration Statement on Form S-4 and related joint proxy statement/prospectus of our report dated March 16, 2022, with respect to the consolidated financial statements of Calidi Biotherapeutics, Inc. (Company) as of December 31, 2021 and 2020 and for the two years then ended which report includes an explanatory paragraph regarding the existence of substantial doubt about the Company’s ability to continue as a going concern. We also consent to the reference to us under the heading “Experts” in this proxy statement / prospectus which is part of this Registration Statement.
/s/ Mayer Hoffman McCann P.C.
Phoenix, Arizona
May 25, 2022